Literature DB >> 30543142

NF1 regulates apoptosis in ovarian cancer cells by targeting MCL1 via miR-142-5p.

Jiancheng Su1, Shaolin Ruan1, Shengkun Dai1, Jing Mi1, Wei Chen2, Songshan Jiang1.   

Abstract

AIM: NF1 loss confers chemoresistance in multiple cancers. However, the etiology remains largely unknown. Our study aimed to scrutinize the role of NF1 in chemoresistant ovarian cancer and its underlying mechanism. MATERIALS &
METHODS: 4',6-diamidino-2-phenylindole staining, terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling assay, luciferase reporter assay, chromatin immunoprecipitation, Western blot, quantitative real-time-PCR and rescue experiments were performed to illustrate the antiapoptotic role of NF1 loss and its underlying mechanism.
RESULTS: NF1-knockdown ovarian cells showed resistance to cisplatin-induced apoptosis. Furthermore, NF1 regulated MCL1 expression at protein level. Further dissections suggested that miR-142-5p was regulated by NF1 via its promoter and targeted MCL1. Consistently, miR-142-5p mimic and si-MCL1 can attenuate the antiapoptotic effect of NF1 knockdown.
CONCLUSION: NF1 knockdown endowed ovarian cells with resistance to cisplatin-induced apoptosis by targeting MCL1 via miR-142-5p.

Entities:  

Keywords:  apoptosis; miR-142-5p; ovarian cancer

Mesh:

Substances:

Year:  2018        PMID: 30543142     DOI: 10.2217/pgs-2018-0161

Source DB:  PubMed          Journal:  Pharmacogenomics        ISSN: 1462-2416            Impact factor:   2.533


  8 in total

Review 1.  A comprehensive survey into the role of microRNAs in ovarian cancer chemoresistance; an updated overview.

Authors:  Ahmad Saburi; Mohammad Saeed Kahrizi; Navid Naghsh; Hasti Etemadi; Ahmet İlhan; Ali Adili; Shadi Ghoreishizadeh; Rozita Tamjidifar; Morteza Akbari; Gülinnaz Ercan
Journal:  J Ovarian Res       Date:  2022-07-07       Impact factor: 5.506

2.  Evaluation of NF1 and RASA1 gene expression in endometriosis.

Authors:  Ghafour Yarahmadi; Mehran Dehghanian; Reyhaneh Sadat Sandoghsaz; Mohamadreza Savaee; Farimah Shamsi; Mohammad Yahya Vahidi Mehrjardi
Journal:  Eur J Obstet Gynecol Reprod Biol X       Date:  2022-05-04

3.  Mining prognostic markers of Asian hepatocellular carcinoma patients based on the apoptosis-related genes.

Authors:  Junbin Yan; Jielu Cao; Zhiyun Chen
Journal:  BMC Cancer       Date:  2021-02-18       Impact factor: 4.430

4.  Long non-coding RNA SNHG20 promotes ovarian cancer development by targeting microRNA-338-3p to regulate MCL1 expression.

Authors:  Ding Wang; Zhiying Li; Hui Li; Jiao Lu; Qi Qin
Journal:  Oncol Lett       Date:  2020-12-18       Impact factor: 2.967

Review 5.  MicroRNAs as the critical regulators of Cisplatin resistance in ovarian cancer cells.

Authors:  Meysam Moghbeli
Journal:  J Ovarian Res       Date:  2021-09-30       Impact factor: 4.234

6.  Altered Expressions of NF1 and NF1-Related microRNAs as Biomarkers in the Diagnosis of Undifferentiated Pleomorphic Sarcoma.

Authors:  Peng Zhang; Lingling Huang; Pengwei Ma; Xiaoying Niu
Journal:  Front Genet       Date:  2022-04-26       Impact factor: 4.772

7.  Transcriptional signatures of the BCL2 family for individualized acute myeloid leukaemia treatment.

Authors:  Chansub Lee; Sungyoung Lee; Eunchae Park; Junshik Hong; Dong-Yeop Shin; Ja Min Byun; Hongseok Yun; Youngil Koh; Sung-Soo Yoon
Journal:  Genome Med       Date:  2022-09-28       Impact factor: 15.266

8.  MiR-142-5p Acts as a Significant Regulator Through Promoting Proliferation, Invasion, and Migration in Breast Cancer Modulated by Targeting SORBS1.

Authors:  Weixuan Yu; Dongwei Li; Yunda Zhang; Cheukfai Li; Chuanzhao Zhang; Libin Wang
Journal:  Technol Cancer Res Treat       Date:  2019 Jan-Dec
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.